Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
出版年份 2022 全文链接
标题
Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses
作者
关键词
-
出版物
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 144, Issue 7, Pages 2905-2920
出版商
American Chemical Society (ACS)
发表日期
2022-02-10
DOI
10.1021/jacs.1c08402
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Property-Unmatched Decoys in Docking Benchmarks
- (2021) Reed M. Stein et al. Journal of Chemical Information and Modeling
- A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening
- (2021) Christoph Gorgulla et al. iScience
- Decision Making in Structure-Based Drug Discovery: Visual Inspection of Docking Results
- (2021) André Fischer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV-2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations
- (2021) Chun-Hui Zhang et al. ACS Central Science
- Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease Inhibitors
- (2021) Naoya Kitamura et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural biology in the time of COVID-19: perspectives on methods and milestones
- (2021) Miranda L. Lynch et al. IUCrJ
- A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
- (2021) Yingzhu Li et al. ACS Central Science
- Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking
- (2021) Marion Schuller et al. Science Advances
- Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLpro)
- (2021) Sang Hoon Han et al. JOURNAL OF MEDICINAL CHEMISTRY
- A practical guide to large-scale docking
- (2021) Brian J. Bender et al. Nature Protocols
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
- (2020) Reed M. Stein et al. NATURE
- Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
- (2020) Anh-Tien Ton et al. Molecular Informatics
- An open-source drug discovery platform enables ultra-large virtual screens
- (2020) Christoph Gorgulla et al. NATURE
- The Development of Coronavirus 3C-Like Protease (3CLpro) Inhibitors from 2010 to 2020
- (2020) Yuzhi Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Drug treatments for covid-19: living systematic review and network meta-analysis
- (2020) Reed AC Siemieniuk et al. BMJ-British Medical Journal
- BioMAX – the first macromolecular crystallography beamline at MAX IV Laboratory
- (2020) Thomas Ursby et al. JOURNAL OF SYNCHROTRON RADIATION
- Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
- (2020) Alice Douangamath et al. Nature Communications
- Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
- (2020) Wayne Vuong et al. Nature Communications
- Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro
- (2020) Dario Akaberi et al. Redox Biology
- Generating multibillion chemical space of readily accessible screening compounds
- (2020) Oleksandr O. Grygorenko et al. iScience
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters
- (2020) Robbert Boudewijns et al. Nature Communications
- Ultra-large library docking for discovering new chemotypes
- (2019) Jiankun Lyu et al. NATURE
- Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability
- (2018) Jin-Feng Yao et al. CURRENT DRUG METABOLISM
- Lipophilic Efficiency as an Important Metric in Drug Design
- (2018) Ted W. Johnson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson’s Disease
- (2018) Mariama Jaiteh et al. JOURNAL OF MEDICINAL CHEMISTRY
- GISAID: Global initiative on sharing all influenza data – from vision to reality
- (2017) Yuelong Shu et al. Eurosurveillance
- Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space
- (2017) Axel Rudling et al. JOURNAL OF MEDICINAL CHEMISTRY
- MolProbity: More and better reference data for improved all-atom structure validation
- (2017) Christopher J. Williams et al. PROTEIN SCIENCE
- AceDRG: a stereochemical description generator for ligands
- (2017) Fei Long et al. Acta Crystallographica Section D-Structural Biology
- Docking Screens for Novel Ligands Conferring New Biology
- (2016) John J. Irwin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro)
- (2015) Sakshi Tomar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ZINC 15 – Ligand Discovery for Everyone
- (2015) Teague Sterling et al. Journal of Chemical Information and Modeling
- PAINS in the Assay: Chemical Mechanisms of Assay Interference and Promiscuous Enzymatic Inhibition Observed during a Sulfhydryl-Scavenging HTS
- (2015) Jayme L. Dahlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of ligand efficiency metrics in drug discovery
- (2014) Andrew L. Hopkins et al. NATURE REVIEWS DRUG DISCOVERY
- Ligand Pose and Orientational Sampling in Molecular Docking
- (2013) Ryan G. Coleman et al. PLoS One
- Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
- (2012) Michael M. Mysinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
- (2012) Jon Jacobs et al. JOURNAL OF MEDICINAL CHEMISTRY
- REFMAC5 for the refinement of macromolecular crystal structures
- (2011) Garib N. Murshudov et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Crystal Structure-Based Virtual Screening for Fragment-like Ligands of the Human Histamine H1Receptor
- (2011) Chris de Graaf et al. JOURNAL OF MEDICINAL CHEMISTRY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- From Structure Diagrams to Visual Chemical Patterns
- (2010) Karen Schomburg et al. Journal of Chemical Information and Modeling
- Rapid Context-Dependent Ligand Desolvation in Molecular Docking
- (2010) Michael M. Mysinger et al. Journal of Chemical Information and Modeling
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More